How to buy Endologix stock (ELGX)

Endologix is a medical instruments & supplies business based in the US. Endologix shares (ELGX) are listed on the NASDAQ and all prices are listed in US Dollars. Endologix employs 488 staff and has a trailing 12-month revenue of around $136.3 million.

Our top picks for where to buy Endologix stock

Buy Endologix stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Endologix stock price (NASDAQ: ELGX)

Use our graph to track the performance of ELGX stocks over time.

Endologix shares at a glance

• Key figures

Information last updated 2021-01-22.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.03
200-day moving average more info button	$0.47
Wall St. target price	$0.88
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-7.27

Is it a good time to buy Endologix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Endologix financials

Revenue TTM	$136.3 million
Gross profit TTM	$91.1 million
Return on assets TTM	-9.82%
Return on equity TTM	0%
Profit margin	-44.65%
Book value	$2.79
Market Capitalization more info button	$4.2 million

TTM: trailing 12 months

Endologix share dividends

We're not expecting Endologix to pay a dividend over the next 12 months.

Have Endologix's shares ever split?

Endologix's shares were split on a 1:10 basis on 5 March 2019 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Endologix shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Endologix shares which in turn could have impacted Endologix's share price.

Endologix share price volatility

Over the last 12 months, Endologix's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Endologix's is 0.735. This would suggest that Endologix's shares are less volatile than average (for this exchange).

Endologix overview

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc.

Frequently asked questions

What percentage of Endologix is owned by insiders or institutions?
Currently 4.693% of Endologix shares are held by insiders and 74.715% by institutions. How many people work for Endologix?
Latest data suggests 488 work at Endologix. When does the fiscal year end for Endologix?
Endologix's fiscal year ends in December. Where is Endologix based?
Endologix's address is: 2 Musick, Irvine, CA, United States, 92618 What is Endologix's ISIN number?
Endologix's international securities identification number is: US29266S3040 What is Endologix's CUSIP number?
Endologix's Committee on Uniform Securities Identification Procedures number is: 14160K102